Brucellosis: a retrospective evaluation of 99 cases and review of brucellosis treatment

被引:20
作者
Demirtuerk, Nee [1 ]
Demirdal, Tuna [1 ]
Erben, Nurettin [2 ]
Demir, Serap [3 ]
Asci, Zerrin [1 ]
Kilit, Pasah [3 ]
Kartal, Elif Doyuk [2 ]
机构
[1] Afyon Kocatepe Univ, Tip Fack Uygulama Arastirma Hastanesi Mavi Hastan, Dept Infect Dis & Clin Microbiol, Sch Med, TR-03200 Afyon, Turkey
[2] Eskisehhir Osmangazi Univ, Sch Med, Dept Infect Dis & Clin Microbiol, Eskisehhir, Turkey
[3] Afyon Kocatepe Univ, Dept Internal Med, Sch Med, TR-03200 Afyon, Turkey
关键词
D O I
10.1258/td.2006.006266
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
This retrospective study was performed in two university hospitals between January 2002 and 2006. Ninety-nine brucellosis patients were included in the study. These patients were classified as acute (91), chronic (4) and relapse (4) according to their clinical presentations and serological tests. Brucella bacteria were isolated in the blood of 17 (17.2%) cases.The most frequent symptom and clinical sign was fever. The osteoarticular complications were found in 17 patients (17.2%). Four of them were complicated with epidural abscess the same time. Two (2.2%) had meningitis, two (2.2%) had epididymoorchitis, three (3.3%) had skin rashes and one (1.1%) had hepatitis. Three of the acute brucellosis patients were pregnant. Rifampin and doxycycline combination therapy had been administered to most of the patients with acute and relapse brucellosis. However, complicated and chronic brucellosis cases were given different treatment combinations. This study reviews brucellosis therapy choices.
引用
收藏
页码:59 / 62
页数:4
相关论文
共 23 条
[1]   QUINOLONES IN TREATMENT OF HUMAN BRUCELLOSIS - COMPARATIVE TRIAL OF OFLOXACIN-RIFAMPIN VERSUS DOXYCYCLINE-RIFAMPIN [J].
AKOVA, M ;
UZUN, O ;
AKALIN, HE ;
HAYRAN, M ;
UNAL, S ;
GUR, D .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (09) :1831-1834
[2]   Risk factors for human brucellosis in Yemen: a case control study [J].
Al-Shamahy, HA ;
Whitty, CJM ;
Wright, SG .
EPIDEMIOLOGY AND INFECTION, 2000, 125 (02) :309-313
[3]   Biotypes and antimicrobial susceptibilities of Brucella isolates [J].
Bodur, H ;
Balaban, N ;
Aksaray, S ;
Yetener, V ;
Akinci, E ;
Çolpan, A ;
Erbay, A .
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2003, 35 (05) :337-338
[4]   Complications associated with Brucella melitensis infection: A study of 530 cases [J].
Colmenero, JD ;
Reguera, JM ;
Martos, F ;
SanchezdeMora, D ;
Delgado, M ;
Causse, M ;
MartinFarfan, A ;
Juarez, C .
MEDICINE, 1996, 75 (04) :195-211
[5]   Quinolones for treatment of human brucellosis: Critical review of the evidence from microbiological and clinical studies [J].
Falagas, ME ;
Bliziotis, IA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (01) :22-33
[6]  
GOTUZZO E, 2004, INFECT DIS, P1717
[7]   The effect of Levamisole combined with the classical treatment in chronic brucellosis [J].
Irmak, H ;
Buzgan, T ;
Karahocagil, MK ;
Evirgen, Ö ;
Akdeniz, H ;
Demiröz, AP .
TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 201 (04) :221-228
[8]   Ofloxacin plus Rifampicin versus Doxycycline plus Rifampicin in the treatment of brucellosis: a randomized clinical trial [ISRCTN11871179] [J].
Karabay, O ;
Sencan, I ;
Kayas, D ;
Sahin, I .
BMC INFECTIOUS DISEASES, 2004, 4 (1)
[9]   Brucellosis in pregnant women [J].
Khan, MY ;
Mah, MW ;
Memish, ZA .
CLINICAL INFECTIOUS DISEASES, 2001, 32 (08) :1172-1177
[10]  
López-Merino A, 2004, SCAND J INFECT DIS, V36, P636, DOI 10.1080/00365540410020767